Gynecology or Gynaecology (see American and British English spelling differences) is the area of medicine concerned with conditions affecting the female reproductive system. It is sometimes combined with the field of obstetrics, which focuses on pregnancy and childbirth, thereby forming the combined area of obstetrics and gynaecology (OB-GYN).
Gynaecology encompasses preventative care, sexual health and diagnosing and treating health issues arising from the female reproduction system, such as the uterus, vagina, cervix, fallopian tubes, ovaries, and breasts; subspecialties include family planning; minimally invasive surgery; paediatric and adolescent gynaecology; and pelvic medicine and reconstructive surgery.
While gynaecology has traditionally centered on women, it increasingly encompasses anyone with female organs, including transgender, intersex, and nonbinary individuals; however, many men face accessibility issues due to stigma, bias, and systemic exclusion in healthcare.
Ayurveda, an Indian traditional medical system, also provides details about concepts and techniques related to gynaecology, addressing fertility, childbirth complications, and menstrual disorders among other things.
The Hippocratic Corpus contains several gynaecological treatises dating to the 5th and 4th centuries BC. Aristotle is another source for medical texts from the 4th century BC with his descriptions of biology primarily found in History of Animals, Parts of Animals, Generation of Animals.
In the early 18th and 19th centuries, in the United States, the field of gyneacology, as with most medical specialities, had ties to black women and therefore slavery. Brothers Henry and Robert Campbell were editors of the first medical journal in the deep south. Henry worked as gynaecologist including on enslaved women, whilst publishing medical case narratives of operations in the journal the brothers edited. This created a conflict of interest. Others, such as Dr. Mary Putnam Jacobi, challenged the exclusion of women from medical education and shifted gynaecology to a scientific practice.Morantz-Sanchez, R. (1985). Sympathy and Science: Women Physicians in American Medicine. Oxford University Press.
J. Marion Sims is regarded as the father of modern gynaecology. Some of his medical contributions were published, such as development of the Sims' position (1845), the Sims' speculum (1845), the Sims' sigmoid catheter, and gynaecological surgery. He was the first to develop surgical techniques for the repair of vesico-vaginal fistulas (1849), a consequence of protracted childbirth which at the time was without treatment. He founded the first women's hospital in the country in Alabama 1855 and subsequently the Woman's Hospital of New York in 1857. He was elected president of the American Medical Association in 1876. Sims died in 1883. His statue was removed from Central Park, after a unanimous vote in 2018.
Sims' legacy is controversial and debated as he conducted experimental operations on black enslaved women, as recounted in his autobiography.
In terms of common procedures used within the now recognised specialism of gynaecology, the first hysteroscopy was completed in 1869 by Pantaleoni, to treat an endometrial polyp, using a Cystoscopy.
Obstetrics and gynaecology were recognised as specialties in the mid-19th century, in the United Kingdom. Specialist societies came into being but it became clear that to become disciplines in their own right a separate college was required. William Fletcher Shaw (Professor of Midwifery at Manchester University) and William Blair-Bell (Professor of Obstetrics at Liverpool University) worked to establish The British College of Obstetricians and Gynaecologists in 1929, this later became the Royal College of Obstetricians and Gynaecologists.
George Nicholas Papanicolaou, from Greece, is credited with discovering the pap smear test, he identified differences in the cytology of normal and Malignancy cervical cells by viewing swabs smeared on microscopic slides. His first publication of the finding in 1928 went relatively unnoticed. It wasn't until he collaborated with Dr Herbert Traut at an American hospital and they published a book, Diagnosis of Uterine Cancer by the Vaginal Smear that this medical advancement became widely known about. By the 20th century, the American College of Obstetricians and Gynecologists (1951) was founded. There were advances in antiseptic techniques, anesthesia, and diagnostic tools, which transformed gynaecological care.Briggs, L. (2002). Reproducing Empire: Race, Sex, Science, and U.S. Imperialism in Puerto Rico. University of California Press.
Some discrimination continued in the United States with forced sterilizations and eugenic policies that disproportionately targeted minorities. In addition to black women, coerced sterilisation was used as a method to restrict perceived undesirable groups from reproducing, such as immigrants, poor people, unmarried mothers, disabled and mentally ill people. Between 1909 and 1979, an estimated 20,000 forced sterilizations occurred in California, primarily in state run mental institutions and prisons. Healthcare later became more focused on the importance of informed consent. Since the 1950's an emphasis on a patients right to choose whether to have treatment or not has existed, albeit with a reliance on those with medical knowledge to advise the best course of treatment. Technological advances have in more recent decades enabled patients themselves to obtain medical information more easily.
In Canada, The Royal College of Physicians and Surgeons did not formally recognize obstetrics & gynaecology as specialist fields until 1957. Obstetrics and gynaecology were considered part of the division of surgery. During the 1940's, practitioners focused on obstetrics and gynaecology began identifying the need for a separate organization to deal with this specialism and the idea to form the Society of Obstetricians and Gynaecologists of Canada (SOGC) was conceived.
Ian Donald, a gynaecologist from the United Kingdom was an early pioneer of the use of sonography within gyneacology and obstetrics. He gained knowledge of radar technology in the air force and working with an engineer called Tom Brown and an engineering company, they developed a compact 2D ultrasound machine. In 1958, he published a paper in the Lancet.
The trials for birth control were controversial for a number of reasons. In 1954, due to anti-birth control laws, the first trials in Massachusetts were positioned as being fertility trials. Gregory Pincus and John Rock conducted these trials. Oral progesterone was tested on fertility patients, with consent, however the oral contraceptive was also tested on 28 psychiatric patients (male and female) at Worcester State Hospital. No direct consent was given by these people, instead relatives gave consent on their behalf. They discovered that women stopped ovulating and that this occurred only whilst taking this. To get FDA approval, a larger clinical trial was needed.
To expand this research, further clinical trials of took place in Puerto Rico, a territory of the United States. Puerto Rico was densely populated with significant poverty, had no anti-birth control laws and already had services offering birth control. Trials began in Rio Piedras in 1956, and women were offered the pill, called Envoid in 1960, on the basis it prevented pregnancy but without knowing it did not have FDA approval. Three women died in the trial and criticisms include that side effects were not taken as seriously as they should have been. Dr. Edris Rice-Wray, a professor at the Puerto Rico Medical School was aware and vocal of the negative side effects of the pill. Although these trials did not follow modern medical ethical practices, they spearheaded the development of the first oral contraceptive.
As with all of medicine, the main tools of diagnosis are clinical history, examination and investigations. Gynaecological examination is quite intimate, more so than a routine physical exam. It can also require instruments such as the speculum. The speculum is used to retract the tissues of the vagina to allow examination of the cervix, the lower part of the uterus located within the upper portion of the vagina. Gynaecologists may do a bimanual examination (one hand on the abdomen and one or two fingers in the vagina) to palpate the cervix, uterus, Ovary and human pelvis. It is not uncommon to do a rectovaginal examination for a complete evaluation of the pelvis, particularly if any suspicious masses are suspected. Gynaecologists may have a chaperone for their examination or a patient can request this.
An abdominal or vaginal ultrasound can be used for diagnostic purposes. This can help to detect growths, such as polyps, endometrial hyperplasmia, carcinoma, endometriosis, pelvic inflammatory disease, polycystic ovary syndrome and many other gynaecology conditions. This is a very common diagnostic tool.
Hormone tests can be useful when investigating gynaecology based conditions or symptoms. These may check the hormone levels of oestradiol, progesterone, follicle stimulating hormone and luteinizing hormones, for example. Levels considered not normal, could indicate the presence of conditions and could impact reproductive function.
Surgery is commonly used to treat gynaecology conditions. In the past, gynaecologists were not considered "surgeons", although this point has always been the source of controversy. Modern advancements in general surgery and gynaecology, have blurred the lines of distinction. The rise of sub-specialties within gynaecology which are primarily surgical in nature (for example urogynaecology and gynaecological oncology) have strengthened the reputations of gynaecologists as surgical practitioners, and many surgeons and surgical societies have come to view gynaecologists as peers. Gynaecologists are now eligible for fellowship in both the American College of Surgeons and Royal Colleges of Surgeons, and many newer surgical textbooks include chapters on (at least basic) gynaecological surgery.
Some of the more common operations that gynaecologists perform include:
There are an increasing number of non-surgical treatments available to help uterine fibroids, along with tranexamic acid and progesterone releasing IUSs, such as contraceptive steroid hormones, gonadotropin releasing hormone (GnRH) agonists and antagonists with and without additional hormones, and selective progesterone receptor modulator (SPRM). Organisations such as the American College of Obstetricians and Gynecologists (ACOG) advocate such treatments before surgical intervention, but studies reveal many women who had a hysterectomy between 2011 and 2019 did not receive any other treatments before this.
Hormone therapy can be used as a non-surgical treatment for endometriosis. Research shows gonadotropin-releasing hormone (GnRH) antagonists, like elagolix, can give encouraging results in managing some symptoms. Also encouraging is research on aromatase inhibitors, such as letrozole that has shown efficacy in reducing lesion size and pain severity. Overall, more recent research shows a trend of new non-surgical treatments becoming available for a number of common gynaecology conditions.
Liquid biopsy is emerging as an important noninvasive tool to detect and monitor gynaecology cancers. Tumor-derived , such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes and microRNA, can provide insights into the biological behavior of gynaecology cancers. Some believe this could revolutionise cancer treatment, assisting with earlier detection and predicting disease recurrence but as of 2025, it is not widely used in clinical practice.
In terms of surgery, research has led to minimally invasive approaches, such as vaginal natural orifice transluminal endoscopic surgery. This technique allows surgeons to access the pelvic cavity through the vaginal canal, reducing recovery times, postoperative pain, and complication rates in comparison to traditional methods.Dückelmann, A. M., & Maia, L. (2023). vNOTES in Modern Gynecology: A Review of Current Evidence and Outcomes. Healthcare
In the United States, obstetrics and gynaecology requires residency training for four years. This encompasses comprehensive clinical and surgical education. OBGYN residents participate in a yearly in-training exam that is administered by the Council on Resident Education in Obstetrics and Gynecology (CREOG). Research suggests that combining curriculum and focused mentorship can improve residents' performance on the exam and overall educational outcomes.
Gynaecologic oncology is a subspecialty of gynaecology, dealing with gynaecology-related cancer. To become a gynaecology oncologist requires specialist further training. Urogynaecology is also a subspecialty of gynaecology and urology. Further fellowship training is needed to become a urogynaecologist.
Speculations on the decreased numbers of male gynaecologist practitioners report a perceived lack of respect from within the medical profession, limited future employment opportunities and questions to the motivations and character of men who choose the medical field concerned with female sexual organs.
Surveys of women's views on the issue of male doctors conducting intimate examinations show a large and consistent majority found it uncomfortable, were more likely to be embarrassed and less likely to talk openly or in detail about personal information, or discuss their sexual history with a man. The findings raised questions about the ability of male gynaecologists to offer quality care to patients. This, when coupled with more women choosing female physicians has decreased the employment opportunities for men choosing to become gynaecologists.
In the United States, it has been reported that four in five students choosing a residency in gynaecology are now female. In several places in Sweden, to comply with discrimination laws, patients may not choose a doctor—regardless of specialty—based on factors such as gender and declining to see a doctor because of their gender may legally be viewed as refusing care. In Turkey, due to patient preference to be seen by another female, there are now few male gynaecologists working in the field.
There have been a number of legal challenges in the US against healthcare providers who have started hiring based on the gender of physicians. Mircea Veleanu argued, in part, that his former employers discriminated against him by accommodating the wishes of female patients who had requested female doctors for intimate exams. A male nurse complained about an advert for an all-female obstetrics and gynaecology practice in Columbia, Maryland, claiming this was a form of sexual discrimination. In 2000, David Garfinkel, a New Jersey-based OB-GYN, sued his former employer after being fired due to, as he claimed, "because I was male, I wasn't drawing as many patients as they'd expected".
Some benign and common gynaecology conditions have been found to disproportionately impact certain racial and ethnic groups. One study found that black women are three times more likely than white women, to have uterine fibroids, a variety of studies found they are more likely to get these at a younger age are more likely to have numerous and rapid growing fibroids. This may be due to biological, lifestyle, environmental and clinical factors, further research is needed to understand why this disparity exists. In regards to endometriosis, some research suggests this disproportionately impacts asian women, with black and hispanic women less likely to have this condition. Research about this is somewhat inconsistent suggesting further studies would be beneficial.
In the United States, health disparities persist in gynaecology, disproportionately affecting women of color, low-income women, and those living in rural areas. Black women face higher rates of mortality from some gynaecology based cancers. The reasons for these disparities is complex and involves racial, economic, educational and geographic factors that influence treatment and survival. Importantly, a variation from evidenced-based treatment has been indicated as a modifiable factor that can effect survival outcomes. This problem disproportionately impacts black women and poorer women. These disparities are compounded by barriers such as lack of insurance and best practice not being followed, particularly when funded by Medicaid.
Some research in the United States shows that hispanic women had a more favorable prognosis compared to non-hispanic women, in regards to certain gynaecology based cancers. With ovarian cancer black women tended to present with more advanced ovarian cancer compared to white women, so were diagnosed at a later stage. The incidence rates of endometrial and ovarian cancer was highest in white women and the incidence of cervical cancer was highest in black women. Research showed that black and hispanic women were less likely to complete the full number of HPV vaccinations, the cause of some gynaecology based cancers. Marginalized groups are less likely to have their pain and symptoms taken seriously by providers, leading to delayed diagnoses and worse outcomes. Addressing these disparities requires having physicians practice cultural humility and physician's addressing their possible bias.
Research from the United States shows that disabled women are screened less for cervical cancer and less likely to have pelvic examinations. They report lower levels of receiving family planning services. Health service usage and whether or not they have insurance did not explain differences in screening levels. Research showed they were less likely to receive doctors recommendations. Women with disabilities also have a greater chance of dying from cervical cancer in counties such as South Korea and Sweden.
In the United Kingdom, in regards to ovarian cancer socioeconomic factors appear to create a disparity in treatment and outcomes. Delays and treatment inequalities may contribute to worse outcomes for women from more deprived areas, with them less likely to receive surgery or chemotherapy. How wealthy a woman is, directly impacted mortality rates. Cervical screening attendance, which helps to diagnose cervical cancer at an early stage has declined, particularly among minority ethnic groups and in more deprived areas. Medical bias in doctor and patient interactions can cause delays to diagnosis and can stem from subconscious stereotypes, in relation to ethnicity or socioeconomic status.
The LGBTQ+ community also face health disparities within gyneacology care. Nearly one in five lesbian and bisexual women have never attended cervical screening. Transexual men and non binary people with a cervix are also less likely to access cervical screening. Research has shown that 22.8% of transgender people avoid accessing healthcare due to anticipated discrimination. Gyneacologists play an important role in caring for transgender patients, who face barriers within health care, as a result of marginalization and discrimination.
Indigenous women in Australia are more likely to die from gynaecology cancers. Research suggests that strategies to reduce survival disparities should target earlier diagnosis and earlier treatment, as aboriginal women were more likely to present with more advanced cancer at the point of diagnosis and decline treatment. Research in Australia examined the issue of pelvic floor dysfunction in aboriginal women, in New South Wales. This showed a high burden of disease and that there was a reluctance of these women to seek care, due to fear of judgement and embarrassment. The authors concluded that culturally appropriate and tailored care was needed to tackle this.
/ref>
Specialist training
Gender of physicians
Health disparities in gynaecology
See also
Sources
External links
|
|